Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

The role of 18F-FDG PET/CT in the imaging of patients with breast cancer.

Created on 19 Jul 2026

Authors

Evangelia Skoura

Published in

Hellenic journal of nuclear medicine. Volume 29 Suppl. Pages 84-86.

Abstract

Diagnosis of the Primary Tumor In initial diagnosis, 18F-FDG PET/CT has questionable clinical value and, for this reason, is not used in routine practice to evaluate potential primary breast tumors. It has low sensitivity but high positive predictive value (PPV) (PPV 81%-100%). So, if increased uptake is found on 18F-FDG PET/CT in a breast lesion as an incidental finding, there is a high probability that it is due to malignancy. The sensitivity of 18F-FDG PET/CT depends on tumor size, histological type (invasive ductal carcinoma has a higher SUVmax than lobular carcinoma, and hormone receptor expression.

PMID:
42472327
Bibliographic data and abstract were imported from PubMed on 19 Jul 2026.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 9
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement